Panbross Pharmaceuticals Private Limited
About Panbross Pharmaceuticals Private Limited
Data last updated:
Panbross Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC047872. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹18.81 Lakh. It is led by directors including Ashawani Kumar Newatia and Bimla Devi Newatia.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 130 Shanta Indl Esti B Patel Road Goregaon, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.79 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net profit of ₹28,413 (net margin 15.8%) and EBITDA of ₹1.11 Lakh (EBITDA margin 62%). Revenue has declined at a compounded annual rate (CAGR) of 82% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Panbross Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address130 Shanta Indl Esti B Patel Road Goregaon, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Panbross Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Panbross Pharmaceuticals Private Limited
FY 2019 filings availablePanbross Pharmaceuticals Private Limited reported revenue of ₹1.79 Lakh (down 98% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 82% over three years, including a 98% fall in the latest year. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.79 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,413 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 62% | ||||
| Net Profit Margin | 15.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Panbross Pharmaceuticals Private Limited, buy the company report.
Board of directors of Panbross Pharmaceuticals Private Limited
Panbross Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashawani Kumar Newatia Also directs: Anaar Pharmaceuticals Private Limited | Director | 31 Oct 2014 | 11 Years 11 Months | Current |
| Bimla Devi Newatia | Director | 02 Jan 2012 | 14 Years 9 Months | Current |
| Gopal Newatia | Director | 31 Oct 2014 | 11 Years 11 Months | Current |
Peer comparison
Panbross Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alviv Pharmaceuticals Private Limited | ₹1.81 Lakh (FY 2019) | Chikuwadi Daman, Daman and Diu, India | ||||
| Lyrist Pharmaceuticals Private Limited | ₹1.81 Lakh (FY 2023) | -45.0% | Gaigath Patna, Bihar, India | |||
| Eyeconic Pharmaceuticals (India) Private Limited | ₹1.81 Lakh (FY 2021) | -91.0% | Aurangabad, Maharashtra, India | |||
| Medethics Pharmaceuticals Private Limited | ₹1.8 Lakh (FY 2024) | -67.0% | Bhubaneswar, Odisha, India | |||
| Ajonsa Pharmaceuticals Private Limited | ₹1.8 Lakh (FY 2025) | -69.0% | Jamnagar, Gujarat, India | |||
| Panbross Pharmaceuticals Private Limitedthis company | ₹1.79 Lakh (FY 2019) | ₹28,413 | 15.8% | -98.0% | 2 | Mumbai, Maharashtra, India |
| Epione Med RX Pharmacy Private Limited | ₹1.79 Lakh (FY 2023) | -99.0% | Jaipur, Rajasthan, India | |||
| Veervill Private Limited | ₹1.79 Lakh (FY 2025) | -46.0% | Thanjavur, Tamil Nadu, India | |||
| Steadmed Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | 153.0% | Kanpur, Uttar Pradesh, India | |||
| Strikar Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Sirois Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | 2540843.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Panbross Pharmaceuticals Private Limited, buy the company report.
Auditor
Panbross Pharmaceuticals Private Limited is audited by A M N & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A M N & ASSOCIATES | FY 2019 | 111928W |
Shareholding
The shareholding of Panbross Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Panbross Pharmaceuticals Private Limited, buy the company report.
Legal cases
Panbross Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Panbross Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Cuttack, Orissa | Civil suit | Filed by the company against Sysmed Laboratories Pvt. Ltd. and Others | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Nimbus Technologies (Rep. Sanjoy Roy) | Disposed |
| Calcutta High Court | Writ petition | Filed by the company against State of WB & Ors | Disposed |
To see the full case history of Panbross Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Panbross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Panbross Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
GST
Panbross Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Panbross Pharmaceuticals Private Limited, buy the company report.
Recent activity
Panbross Pharmaceuticals Private Limited has 8 board changes on record since 2012: 3 appointments and 5 cessations. The latest: Jayanta Dey ceased to be Director on 30 Sep 2017.
Frequently asked questions
Panbross Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 1988 (38+ years old) and is registered under CIN U24230MH1988PTC047872.
Panbross Pharmaceuticals has 3 current directors:
- Ashawani Kumar Newatia - Director
- Bimla Devi Newatia - Director
- Gopal Newatia - Director
The latest financial statements of Panbross Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Panbross Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Panbross Pharmaceuticals is U24230MH1988PTC047872. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Panbross Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the district courts.
Panbross Pharmaceuticals was incorporated on 29 June 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Panbross Pharmaceuticals by revenue are Alviv Pharmaceuticals Private Limited, Lyrist Pharmaceuticals Private Limited, Eyeconic Pharmaceuticals (India) Private Limited, Medethics Pharmaceuticals Private Limited, Ajonsa Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Jayanta Dey ceased to be Director on 30 Sep 2017. Nishith Mondal ceased to be Director on 30 Sep 2017. Ashawani Kumar Newatia ceased to be Additional Director on 30 Sep 2015. Panbross Pharmaceuticals has 8 board changes on record in total.
The registered office of Panbross Pharmaceuticals is at 130 Shanta Indl Esti B Patel Road Goregaon, Mumbai, Maharashtra, India – 400063.
Panbross Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.